CLINICAL_TRIALS
trial_result
· 2026-08-17
Clinical Trial Update: ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars [Phase 3]
Summary
Phase 3 clinical trial of ELAPR002f injectable gel for atrophic acne scars has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbbVie | Conditions: Atrophic Acne Scars | Phase 3 | Status: COMPLETED